EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.3600
+0.0100 (2.86%)
Oct 9, 2026, 4:10 PM AEST
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 16.94 million as of October 9, 2026. It is the 40,676th most valuable company in the world and the 1,150th biggest in Australia. Its market cap has decreased by 85.80% in one year.
Market Cap
16.94M
Enterprise Value
6.54M
Revenue
46.28M
Global Rank
Country Rank
#1,150 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has decreased from 48.72M to 16.94M, a decrease of -65.22%. That is a compound annual growth rate of -17.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 16.94M | -74.45% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
| Mar 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 21.69M |
| Imugene | 20.57M |
| Proteomics International Laboratories | 19.84M |
| Noxopharm | 18.74M |
| Patrys | 18.63M |
| Algorae Pharmaceuticals | 18.25M |
| Ceryvyn Therapeutics | 17.78M |
| Cambium Bio | 15.89M |